Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world post-marketing safety evaluation of Agkistrodon acutus hemocoagulase and azithromycin in children
ChiCTR2500104309Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Jun 2025
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of hemocoagulase agkistrodon and azithromycin in Bleeding and bacterial disease (2 arms), sponsored by Union Hospital. Primary endpoint: Adverse reaction incidence rate. Started Jun 2025; status: recruiting.
02
Drugs
hemocoagulase agkistrodonazithromycin
03
Conditions
Bleedingbacterial disease
Beyond the preview
Go deeper on ChiCTR2500104309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104309.